about
Ribonucleases as novel chemotherapeutics : the ranpirnase exampleRibonuclease A Homologues of the Zebrafish: Polymorphism, Crystal Structures of Two Representatives and their Evolutionary ImplicationsOnconase and amphinase, the antitumor ribonucleases from Rana pipiens oocytesMicrobial ribonucleases (RNases): production and application potential.Comparative functional analysis of ribonuclease 1 homologs: Molecular insights into evolving vertebrate physiology.Arginine residues are more effective than lysine residues in eliciting the cellular uptake of onconase.Cellular uptake of ribonuclease A relies on anionic glycans.A human ribonuclease induces apoptosis associated with p21WAF1/CIP1 induction and JNK inactivation.Adenovirus-mediated hPNPase(old-35) gene transfer as a therapeutic strategy for neuroblastomaAntitumor activity of ribonuclease multimers created by site-specific covalent tethering.Cytostatic and cytotoxic properties of Amphinase: a novel cytotoxic ribonuclease from Rana pipiens oocytes.Human ribonuclease with a pendant poly(ethylene glycol) inhibits tumor growth in mice.Evasion of ribonuclease inhibitor as a determinant of ribonuclease cytotoxicityRanpirnase and its potential for the treatment of unresectable malignant mesotheliomaRibonucleases as potential modalities in anticancer therapyEvaluation of human pancreatic RNase as effector molecule in a therapeutic antibody platform.Antibody-enzyme fusion proteins for cancer therapy.Potentiation of ribonuclease cytotoxicity by a poly(amidoamine) dendrimer.Onconase cytotoxicity relies on the distribution of its positive charge.Contribution of the C30/C75 disulfide bond to the biological properties of onconase.Remarkable enhancement of cytotoxicity of onconase and cepharanthine when used in combination on various tumor cell lines.Cytotoxic ribonucleases: the dichotomy of Coulombic forces.Design and characterization of an HIV-specific ribonuclease zymogen.Contribution of electrostatics to the binding of pancreatic-type ribonucleases to membranes.Chemosensitivity of conjunctival melanoma cell lines to target-specific chemotherapeutic agents.Updates in the Development of ImmunoRNases for the Selective Killing of Tumor Cells.The nuclear transport capacity of a human-pancreatic ribonuclease variant is critical for its cytotoxicity.Targeted therapeutic RNases (ImmunoRNases)
P2860
Q24650138-3FA13F9B-F7F9-4F69-8E3A-7DF69354F8A5Q27650702-DD3CE72D-2829-4C40-A090-1B933E4102D0Q28289485-9DA2C944-E4FA-4F27-825D-D680050AE3C1Q30379895-980426F0-6ABE-49C7-B999-3FC14E1EAFCAQ30401888-83E328D6-81D6-4863-AB2F-22DD4CC974B6Q30407943-09A78A58-14B4-44B9-9E85-7381E33164C7Q33742595-92987077-D6F8-4645-898C-9B6C923C5C2EQ33790446-F40A62B3-718A-43A7-8D3C-E8D9D04738B7Q34065928-D90FF7BA-DCCA-4353-9819-092FE19D9038Q34130092-CD48772D-2D9D-453E-9D14-27BC4830214BQ36982671-61582123-FDC2-4A17-9662-650E3F10280CQ37060935-9A72C30D-A8C8-482A-9005-DD822185B4F7Q37233080-01FE84BC-AF73-4F74-8562-DCA5627F7149Q37307815-6412BFAB-D07A-45E6-9D99-DDC258C18225Q37441874-7FD14324-B55E-48A1-87E6-67A63E10E762Q37698918-68C6759F-4886-4B65-8BA2-8E080F1AE228Q37842324-FFE5B0E5-8BF2-43E8-83BF-F0A591C296BDQ39622189-E96374F6-A2C3-43AB-9E18-306AA202D69BQ39838747-F4CCC2D4-8C6E-4934-8C7D-1069974704E2Q39922181-CBA5234E-66B0-4667-B168-875D63EF672CQ39987355-841BA721-3DFB-4ECA-9E1F-5029B00545ABQ40367555-5B3715A6-0485-4430-85B6-8578A9417DC7Q41204627-D05B7702-D474-4314-9DAC-D33EFBFC3E6BQ42869373-5C128801-67D8-4FA6-8FCD-54768D2961D4Q46597170-D0742A31-161B-4AA6-A0F2-6390693A70BEQ54261268-3C43A260-D2C9-4026-AD71-90D2F9895A9AQ55052763-5DC2B47F-ED4B-4EBB-8688-C5733DD1A927Q58008126-CCABA4FE-49D0-45D2-904F-320F8D07F6CC
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
On the track of antitumour ribonucleases.
@ast
On the track of antitumour ribonucleases.
@en
type
label
On the track of antitumour ribonucleases.
@ast
On the track of antitumour ribonucleases.
@en
prefLabel
On the track of antitumour ribonucleases.
@ast
On the track of antitumour ribonucleases.
@en
P2093
P2860
P356
P1433
P1476
On the track of antitumour ribonucleases.
@en
P2093
Antoni Benito
Maria Vilanova
P2860
P304
P356
10.1039/B502847G
P577
2005-09-22T00:00:00Z